SERPIN PHARMA

Our story began with a team of scientists and visionaries looking to tackle one of healthcare's greatest unmet needs: inflammatory diseases. When we recognized the potential for SERPIN proteins to mitigate these conditions, we committed to developing a first-in-class therapeutic to restore immune balance to harmful inflammatory environments... Our therapeutic, now known as SP16, is currently undergoing pre-clinical and clinical trials for a broad span of orphan, chronic, and acute indications. We are currently collaborating with leaders across diverse fields of research to deliver our technology to the patients who need it most... We believe that Serpin Pharma's therapeutics are poised to shift the inflammatory disease landscape and provide lifelong solutions for a broad patient population.

Also known as: Serpin Pharma, LLC

Primary location: Manassas United States